OpenAlex
PricingAboutJobs
Log inGet started
Work

MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?

HTML

Year: 2019
Type: article
Source: European Journal of Endocrinology
DOI: 10.1530/eje-19-0566
Authors: Michael A Nauck, Juris J Meier
Institutions: St. Josef-Hospital, Ruhr University Bochum
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, type 2 diabetes, exenatide, liraglutide, semaglutide, dulaglutide, albiglutide, lixisenatide, oral semaglutide, pharmacokinetics, glycemic control, weight loss, cardiovascular outcomes, major adverse cardiovascular events, cardiovascular mortality, heart failure, pre-existing cardiovascular disease
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2979558564
FWCI: 16.21
Cites: 91
Cited by: 294
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security